Lorvotzumab Mertansine (NCAM1/CD56) - Onderzoeksgraad Biosimilar
Kwaliteit
ISO Gecertificeerd
Levering
24-48 uur
Technische Specificaties
Lorvotuzumab mertansine has been used in trials studying the treatment of SCLC, Leukemia, Ovarian Cancer, Multiple Myeloma, and Merkel Cell Carcinoma, among others.
Humanized / NCAM1/CD56 [Homo sapiens]
• Recombinant Monoclonal
Unconjugated
Primary Antibodies, Biosimilars
CHO cells
Cancer
>95%
Batch dependent
PBS buffer pH7.5
None
Blue Ice
Use a manual defrost freezer and avoid repeated freeze thaw cycles. Store at 2 to 8 ˚ C for 1-2 weeks. Store at -20 ˚ C for 12 months. Store at -80 ˚ C for long term storage.
IgG1-kappa
Homo sapiens
BB-10901, IMGN901, huN901-DM1, NCAM1/CD56, NCAM1/CD56
Beschrijving
Lorvotzumab Mertansine (NCAM1/CD56) - Onderzoeksgraad Biosimilar Beschikbaar in 0.1 mg. Bestel eenvoudig online met snelle levering.
Specificaties
Recent bekeken producten
K562-HLA-G0101 Overexpressing Cell Line
RG-1214
5x 10^6
Yeast Poly (A) Polymerase
RNT-006-S
30000 Units
Arachis hypogaea Lectin (PNA) - Biotinylated
21510020-1
5mg
Arachis hypogaea lectin (PNA)
05-0116-10mg
10 mg
Anti-APOE2 mouse monoclonal antibody
TD-AB0132
100 µg
Human Apolipoprotein E2 (Apo E2) Antibody
22210-05011
150 µg
DiagPoly™ Carboxyl Fluorescent Polystyrene Particles, Green, 1 µm
DCFG-L007
1 mL
DiagPoly™ Carboxyl Polystyrene Particles, 1.0 µm
DNM-F029
10 mL
